Barr Pharmaceuticals/PLIVA - pharmaceutical, behavioral healthcare, medical, hmo, ppo, hospital, diagnostic, market, overview, busintell reports, information, prescription, spectrum, blue cross, anthem, aetna, insurance plan, managed care, knowledge source

About Us

My Account

View Cart

Home » Knowledge Source Spotlight » Generic Pharmaceutical Companies » Barr Pharmaceuticals/PLIVA

Publication Details

Barr Pharmaceuticals/PLIVA

Generic Keywords: (What are these?)
Knowledge Source, Healthcare Market, BusIntell, Reports, Medical, Information, HMO, Pharmacare, Diagnostic

Publication Date: 25-FEB-07
Pages: 1

Description
Barr Pharmaceuticals' subsidiary PLIVA received final approval from the FDA for its Abbreviated New Drug Application to manufacture and market Sertraline Hydrochloride Tablets, 25 mg, 50 mg and 100 mg, generic versions of Pfizer Inc.'s ZOLOFT(R) Tablets.

	Home

	Healthcare Market Overviews

	BusIntell Reports

	Pharmaceutical Brand Briefings

	Conference Interviews

	HealthDot Pharma Report

	Spotlight

	Custom Research

	Content Map

	Home Healthcare Market Overviews BusIntell Reports Events on Demand Spotlight Custom Research Content Map